United States: Mere Clinical Testing In A District May Be Insufficient To Establish Venue For A Patent Infringement Action Based On The Safe-Harbor Provision Of § 271(E)(1)


The patent statute safe harbor provision prevents liability for mere clinical testing. So a defendant may challenge a patent owner's choice of venue for litigation if the acts of infringement in that venue are covered by the safe harbor provision for clinical testing. And a defendant may successfully challenge such venue by summary judgment on such basis even if non-except acts of infringement that did not involve clinical testing occurred in other locations outside that venue.  In responding to such venue challenge that no non-exempt acts of infringement occurred in the selected venue, a plaintiff cannot rely on mere venue allegations in its complaint but needs to present evidence of non-exempt acts of infringement in the selected venue.


Snyders Heart Valve sued St. Jude Medical in Texas for infringing its patents related to artificial heart valves. St. Jude alleged its products were designed and manufactured in Minnesota and any sales of those products in Texas were not for commercial purposes, but rather for clinical testing, a defense to infringement liability covered under the safe harbor provision of  §271(e)(1).

St. Jude moved to dismiss, asserting that Texas was an improper venue for litigation. The court denied that motion because the law, at the time, provided that venue was proper for litigation where a plaintiff made a prima facie showing that a defendant was subject to personal jurisdiction in the district of the court in which the litigation was filed. Ten days later, the U.S. Supreme Court changed the venue law in deciding the TC Heartland  case, and St. Jude subsequently asked the Texas court to reconsider its venue decision in light of TC Heartland.

The Texas magistrate's report on the motion for reconsideration focused on whether the acts of alleged infringement occurred in the district and, thus, whether all sales of the accused products in the district are subject to the safe harbor provided in § 271(e)(1). Finding that the safe harbor statute provided the basis for an affirmative defense and that a plaintiff should not be required to negate an affirmative defense at a motion to dismiss stage, the report recommended denying St. Jude's motion for reconsideration.

Before the Court adopted the report, St. Jude moved for summary judgment for improper venue arguing that no acts of infringement occurred in the Eastern District of Texas because all of its activities in the district were covered by the safe harbor provision. The Court ultimately agreed with St. Jude.

The Snyders Decision

Because St. Jude was not incorporated in Texas, the Court focused on (1) the relevance of a "safe harbor" defense when determining venue and (2) whether the safe harbor is an "all-or-nothing" defense.

As to the first issue, the Court found that safe harbor was relevant to the venue determination. Reviewing the language of the safe harbor defense under § 217(e)(1) and the venue statute under § 1400(b), the Court noted that both speak of "acts of infringement" not acts of "alleged" infringement. So at the summary judgement stage, once a defendant comes forward with evidence that the accused acts of infringement in the district are solely clinical trials covered by the safe harbor defense of § 217(e)(1), venue is improper and a plaintiff cannot rely on mere allegations of infringement in its complaint to rebut summary judgment.

As to the second issue, the Court rejected Snyders's argument that the safe harbor defense was an "all or nothing" defense. Under Snyder's theory, once a defendant makes and sells the accused products anywhere in the United States for commercial purposes, none of the sales are protected by the safe harbor provision. Relying on Federal Circuit precedent, the Court explained that the law requires "each use of a patented invention be evaluated separately" when determining whether the safe harbor provision applies. The relevant inquiry here was not whether St. Jude engaged in uses outside the District that are not "solely" or "reasonably related" to seeking FDA approval, but rather, whether St. Jude had engaged in any such uses in this  District so that venue is proper. The Court ultimately found that all of St. Jude's acts of infringement in the Eastern District of Texas were clinical and therefore exempt under the safe harbor provision, despite non-exempt activity in Minnesota.

Synders also made a procedural challenge to St. Jude's motion for summary judgment, arguing the motion was improper and untimely based on the prior denial of St. Jude's motion to dismiss and the findings from the Court that a plaintiff should not have to negate an affirmative defense to overcome a venue challenge. The Court disagreed and found the issue of venue could be revisited once there is a determination of noninfringement on the merits and can be decided after the case has passed the stage when motion to dismiss are filed.

Strategy and Conclusion

Venue challenges can be raised past the stage when motions to dismiss are filed, and parties should be aware of the relationship between the safe harbor provision of § 271(1)(e) and the requirements of the venue statute to seek and provide the relevant and proper discovery to establish or challenge venue in a specific district. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
11 Dec 2018, Conference, Washington, DC, United States

Finnegan partner Li Feng will present "How to Read & Write Patents and Scientific Publications"at the 72nd annual Scientific Meeting & Technology Showcase, hosted by the Society of Cosmetic Chemists.

11 Dec 2018, Conference, Washington, DC, United States

Finnegan is a Conference App sponsor of DeviceTalks West, hosted by MassDevice. The program will take place at the Hilton Orange County hotel in Costa Mesa, California.

12 Dec 2018, Seminar, Washington, DC, United States

Finnegan partner Anthony Tridico will present “U.S. Case Law Update” during the Chartered Institute of Patent Attorneys’ Patent Case Law program.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions